For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

Longer treatment duration, not having diabetes, and using semaglutide are among the factors linked to better weight reduction over 12 months.

For adults with T2D and obesity, GLP-1 RAs are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other antidiabetic drugs.

Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...

A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...

If you have elevated A1C levels or have already been diagnosed with type 2 diabetes, it’s best to aim for an A1C that’s less ...